161 related articles for article (PubMed ID: 18563576)
21. Characterization of spray dried powders with nucleic acid-containing PEI nanoparticles.
Keil TWM; Feldmann DP; Costabile G; Zhong Q; da Rocha S; Merkel OM
Eur J Pharm Biopharm; 2019 Oct; 143():61-69. PubMed ID: 31445157
[TBL] [Abstract][Full Text] [Related]
22. Development of a novel and customizable two-solution mixing type spray nozzle for one-step preparation of nanoparticle-containing microparticles.
Ozeki T; Akiyama Y; Takahashi N; Tagami T; Tanaka T; Fujii M; Okada H
Biol Pharm Bull; 2012; 35(11):1926-31. PubMed ID: 23123464
[TBL] [Abstract][Full Text] [Related]
23. Preparation of two-drug composite microparticles to improve the dissolution of insoluble drug in water for use with a 4-fluid nozzle spray drier.
Ozeki T; Beppu S; Mizoe T; Takashima Y; Yuasa H; Okada H
J Control Release; 2005 Oct; 107(3):387-94. PubMed ID: 16126298
[TBL] [Abstract][Full Text] [Related]
24. Lecithin/TPGS-based spray-dried self-microemulsifying drug delivery systems: In vitro pulmonary deposition and cytotoxicity.
Ishak RA; Osman R
Int J Pharm; 2015 May; 485(1-2):249-60. PubMed ID: 25772421
[TBL] [Abstract][Full Text] [Related]
25. Fabrication of nanocomposite particles using a two-solution mixing-type spray nozzle for use in an inhaled curcumin formulation.
Taki M; Tagami T; Fukushige K; Ozeki T
Int J Pharm; 2016 Sep; 511(1):104-110. PubMed ID: 27374204
[TBL] [Abstract][Full Text] [Related]
26. Microparticles of rifampicin: comparison of pulmonary route with oral route for drug uptake by alveolar macrophages, phagocytosis activity and toxicity study in albino rats.
Parikh R; Patel L; Dalwadi S
Drug Deliv; 2014 Sep; 21(6):406-11. PubMed ID: 24215141
[TBL] [Abstract][Full Text] [Related]
27. Porous and highly dispersible voriconazole dry powders produced by spray freeze drying for pulmonary delivery with efficient lung deposition.
Liao Q; Yip L; Chow MYT; Chow SF; Chan HK; Kwok PCL; Lam JKW
Int J Pharm; 2019 Apr; 560():144-154. PubMed ID: 30731259
[TBL] [Abstract][Full Text] [Related]
28. Influence of stabilizer type and concentration on the lung deposition and retention of resveratrol nanosuspension-in-microparticles.
Liu Q; Guan J; Sun Z; Shen X; Li L; Jin L; Mao S
Int J Pharm; 2019 Oct; 569():118562. PubMed ID: 31351178
[TBL] [Abstract][Full Text] [Related]
29. Rifampicin loaded mannosylated cationic nanostructured lipid carriers for alveolar macrophage-specific delivery.
Song X; Lin Q; Guo L; Fu Y; Han J; Ke H; Sun X; Gong T; Zhang Z
Pharm Res; 2015 May; 32(5):1741-51. PubMed ID: 25407545
[TBL] [Abstract][Full Text] [Related]
30. The influence of mannitol on morphology and disintegration of spray-dried nano-embedded microparticles.
Torge A; Grützmacher P; Mücklich F; Schneider M
Eur J Pharm Sci; 2017 Jun; 104():171-179. PubMed ID: 28390837
[TBL] [Abstract][Full Text] [Related]
31. Phospholipid-based pyrazinamide spray-dried inhalable powders for treating tuberculosis.
Eedara BB; Tucker IG; Das SC
Int J Pharm; 2016 Jun; 506(1-2):174-83. PubMed ID: 27091294
[TBL] [Abstract][Full Text] [Related]
32. Nano-liposomal dry powder inhaler of Amiloride Hydrochloride.
Chougule MB; Padhi BK; Misra A
J Nanosci Nanotechnol; 2006; 6(9-10):3001-9. PubMed ID: 17048511
[TBL] [Abstract][Full Text] [Related]
33. Arbekacin-Loaded Inhalable Nanocomposite Particles Specific to Pseudomonas aeruginosa Prepared Using a Two-Solution Mixing-Type Spray Nozzle.
Yamamoto N; Tagami T; Ogawa K; Ozeki T
Biol Pharm Bull; 2023; 46(2):201-208. PubMed ID: 36724949
[TBL] [Abstract][Full Text] [Related]
34. Dry-Powder Inhaler Formulation of Rifampicin: An Improved Targeted Delivery System for Alveolar Tuberculosis.
Rawal T; Kremer L; Halloum I; Butani S
J Aerosol Med Pulm Drug Deliv; 2017 Dec; 30(6):388-398. PubMed ID: 28510480
[TBL] [Abstract][Full Text] [Related]
35. Co-Spray Dried Nafamostat Mesylate with Lecithin and Mannitol as Respirable Microparticles for Targeted Pulmonary Delivery: Pharmacokinetics and Lung Distribution in Rats.
Kang JH; Kim YJ; Yang MS; Shin DH; Kim DW; Park IY; Park CW
Pharmaceutics; 2021 Sep; 13(9):. PubMed ID: 34575594
[TBL] [Abstract][Full Text] [Related]
36. Co-spray drying of hygroscopic kanamycin with the hydrophobic drug rifampicin to improve the aerosolization of kanamycin powder for treating respiratory infections.
Momin MAM; Tucker IG; Doyle CS; Denman JA; Sinha S; Das SC
Int J Pharm; 2018 Apr; 541(1-2):26-36. PubMed ID: 29458207
[TBL] [Abstract][Full Text] [Related]
37. Co-Spray Dried Mannitol/Poly(amidoamine)-Doxorubicin Dry-Powder Inhaler Formulations for Lung Adenocarcinoma: Morphology, In Vitro Evaluation, and Aerodynamic Performance.
Zhong Q
AAPS PharmSciTech; 2018 Feb; 19(2):531-540. PubMed ID: 28840529
[TBL] [Abstract][Full Text] [Related]
38. Inhalable microparticles containing large payload of anti-tuberculosis drugs.
Muttil P; Kaur J; Kumar K; Yadav AB; Sharma R; Misra A
Eur J Pharm Sci; 2007 Oct; 32(2):140-50. PubMed ID: 17681458
[TBL] [Abstract][Full Text] [Related]
39. Effect of particle size of dry powder mannitol on the lung deposition in healthy volunteers.
Glover W; Chan HK; Eberl S; Daviskas E; Verschuer J
Int J Pharm; 2008 Feb; 349(1-2):314-22. PubMed ID: 17904774
[TBL] [Abstract][Full Text] [Related]
40. Development of dry powder inhaler formulation loaded with alendronate solid lipid nanoparticles: solid-state characterization and aerosol dispersion performance.
Ezzati Nazhad Dolatabadi J; Hamishehkar H; Valizadeh H
Drug Dev Ind Pharm; 2015; 41(9):1431-7. PubMed ID: 25220930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
